|

货币单位:美元(USD)

Aprinoia Therapeutics, Inc. (apri)

实时(?):

盘后(?):

读取中...

-- (--%)

开盘价:--	最高价:--	最低价:--	52周最高价:--	52周最低价:--
成交量:--	平均成交量:--	市值:--	市盈率:--	预期市盈率:--
每股收益:--	贝塔系数:--	股息:--	收益率:--	总股本:--

提示:交易结束

Chien Hui Hung	Chien Hui Hung is currently working as an Operations Director at Aprinoia Therapeutics, Inc. Previously, Ms. Hung worked as Head-Accounting at Azion Corp.
Ming-Kuei Jang	Ming-Kuei Jang is the founder of Aprinoia Therapeutics, Inc. (founded in 2015) where he holds the title of Chief Executive Officer. He is also the founder of Aprinoia Therapeutics, Inc. (founded in 2015) where he holds the title of Chairman & President-Asia Operations. Currently, Dr. Jang is the Chief Scientific Officer at APRINOIA Therapeutics LLC. In the past, he worked as an Associate Director at Glaxosmithkline China Ltd. from 2010 to 2012. Dr. Jang completed his undergraduate studies at National Taiwan University and obtained a doctorate degree from Boston University School of Medicine.

Chien Hui Hung

Chien Hui Hung is currently working as an Operations Director at Aprinoia Therapeutics, Inc. Previously, Ms. Hung worked as Head-Accounting at Azion Corp.

Ming-Kuei Jang

Ming-Kuei Jang is the founder of Aprinoia Therapeutics, Inc. (founded in 2015) where he holds the title of Chief Executive Officer. He is also the founder of Aprinoia Therapeutics, Inc. (founded in 2015) where he holds the title of Chairman & President-Asia Operations. Currently, Dr. Jang is the Chief Scientific Officer at APRINOIA Therapeutics LLC. In the past, he worked as an Associate Director at Glaxosmithkline China Ltd. from 2010 to 2012. Dr. Jang completed his undergraduate studies at National Taiwan University and obtained a doctorate degree from Boston University School of Medicine.